JAGX (Jaguar Health, Inc.) Stock Analysis - AI Report

Jaguar Health, Inc. (JAGX) is a publicly traded Healthcare sector company. As of May 21, 2026, JAGX trades at $3.51 with a market cap of $1.90M and a P/E ratio of -0.16. JAGX moved +0.00% today. Year to date, JAGX is -88.80%; over the trailing twelve months it is -98.02%. Its 52-week range spans $2.53 to $1,121.59. Rallies surfaces JAGX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the AI research view on JAGX?

Rallies AI research for JAGX combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.

JAGX Key Metrics

Key financial metrics for JAGX
MetricValue
Price$3.51
Market Cap$1.90M
P/E Ratio-0.16
EPS$-22.97
Dividend Yield0.00%
52-Week High$1,121.59
52-Week Low$2.53
Volume29.76K
Avg Volume0
Revenue (TTM)$11.51M
Net Income$-54.00M
Gross Margin67.21%

Latest JAGX News

JAGX Analyst Consensus

JAGX analyst coverage data. Average price target: $0.00.

Common questions about JAGX

What is the AI research view on JAGX?
Rallies AI research for JAGX combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for JAGX?
Rallies AI research for JAGX combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is JAGX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for JAGX. It does not provide personalized investment advice.
JAGX

JAGX